Close Menu
Home › Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

Aug 01, 2019
|
staff reporter

This story has been updated with additional details from UnitedHealthcare's coverage policy.

NEW YORK – UnitedHealthcare has issued a positive coverage decision for Myriad Genetics' GeneSight Psychotropic pharmacogenetic test, Myriad disclosed in a filing with the US Securities and Exchange Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

  2. Myriad Genetics Stock Plummets on Lower-Than-Expected Q4 Revenues, FDA Interactions on GeneSight

  3. BioMérieux Developing Advanced Analytics to Support Hospitals' Antimicrobial Stewardship Initiatives

    Premium

  4. Agilent Q3 Revenues Up 6 Percent

  5. Fulgent Genetics to Offer $75M of Securities

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.